Humoral Immunogenicity and Efficacy of a Single Dose of ChAdOx1 MERS Vaccine Candidate in Dromedary Camels

Development and validation of different indirect ELISAs for MERS-CoV serological testing

(2019) Anwar M. Hashem et al.   JOURNAL OF IMMUNOLOGICAL METHODS

A highly immunogenic, protective and safe adenovirus-based vaccine expressing MERS-CoV S1-CD40L fusion protein in transgenic human DPP4 mouse model

(2019) Anwar M Hashem et al.   JOURNAL OF INFECTIOUS DISEASES

Protective Antibodies Against Influenza Proteins

(2019) Herbey O. Padilla-Quirarte et al.   Frontiers in Immunology

Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus

(2019) Chean Yeah Yong et al.   Frontiers in Microbiology

MERS coronaviruses from camels in Africa exhibit region-dependent genetic diversity

(2018) Daniel K. W. Chu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cross-sectional study of MERS-CoV-specific RNA and antibodies in animals that have had contact with MERS patients in Saudi Arabia

(2018) Samy Kasem et al.   Journal of Infection and Public Health

The prevalence of Middle East respiratory Syndrome coronavirus (MERS-CoV) infection in livestock and temporal relation to locations and seasons

(2018) Samy Kasem et al.   Journal of Infection and Public Health

Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults

(2018) L. Coughlan et al.   EBioMedicine

Prospects for a MERS-CoV spike vaccine

(2018) Yusen Zhou et al.   Expert Review of Vaccines

Reported Direct and Indirect Contact with Dromedary Camels among Laboratory-Confirmed MERS-CoV Cases

(2018) Romy Conzade et al.   Viruses-Basel

High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia

(2018) Abeer N. Alshukairi et al.   mBio

Risk factors for MERS coronavirus infection in dromedary camels in Burkina Faso, Ethiopia, and Morocco, 2015

(2017) Eve Miguel et al.   Eurosurveillance

A study of the probable transmission routes of MERS-CoV during the first hospital outbreak in the Republic of Korea

(2017) S. Xiao et al.   INDOOR AIR

ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice

(2017) Naif Khalaf Alharbi et al.   VACCINE

Diversity of Middle East respiratory syndrome coronaviruses in 109 dromedary camels based on full-genome sequencing, Abu Dhabi, United Arab Emirates

(2017) Mohammed Farouk Yusof et al.   Emerging Microbes & Infections

Longitudinal study of Middle East Respiratory Syndrome coronavirus infection in dromedary camel herds in Saudi Arabia, 2014–2015

(2017) Maged Gomaa Hemida et al.   Emerging Microbes & Infections

Systematic, active surveillance for Middle East respiratory syndrome coronavirus in camels in Egypt

(2017) Mohamed A Ali et al.   Emerging Microbes & Infections

Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model

(2017) Vincent J. Munster et al.   npj Vaccines

Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction

(2017) V M Corman et al.   Eurosurveillance

Vaccines against Middle East respiratory syndrome coronavirus for humans and camels

(2016) Naif Khalaf Alharbi   REVIEWS IN MEDICAL VIROLOGY

Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever

(2016) George M. Warimwe et al.   Scientific Reports

Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein

(2015) Asisa Volz et al.   JOURNAL OF VIROLOGY

Serological Evidence of MERS-CoV Antibodies in Dromedary Camels (Camelus dromedaries) in Laikipia County, Kenya

(2015) Sharon L. Deem et al.   PLoS One

An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels

(2015) B. L. Haagmans et al.   SCIENCE

Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity

(2014) M G Hemida et al.   Eurosurveillance

Evidence for Camel-to-Human Transmission of MERS Coronavirus

(2014) Esam I. Azhar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013

(2013) R Perera et al.   Eurosurveillance

Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study

(2013) Chantal BEM Reusken et al.   LANCET INFECTIOUS DISEASES

Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens

(2013) Richard D Antrobus et al.   MOLECULAR THERAPY

Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26

(2013) Guangwen Lu et al.   NATURE

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

(2013) V. Stalin Raj et al.   NATURE

A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity

(2012) Matthew D. J. Dicks et al.   PLoS One

Experimental infection of bats with Geomyces destructans causes white-nose syndrome

(2011) Jeffrey M. Lorch et al.   NATURE

Effective induction of high-titer antibodies by viral vector vaccines

(2008) Simon J Draper et al.   NATURE MEDICINE